Download and view our expert content

Frontage offers comprehensive preclinical to clinical oncology services, taking you from drug discovery to clinical development.

Frontage supports early drug discovery with various immunoassays for proteins and therapeutic antibodies to support pharmacokinetics/toxicokinetics (PK/TK), pharmacodynamics (PD), and biomarkers analysis.

​Frontage’s Biologics, Gene, and Cell Therapy Operations (BGC) Unit supports the development of biologics products. We develop complex analytical techniques to support drug substances, drug products, comparability studies, and stability programs.

In this infographic, we report on key future trends in precision medicine and companion diagnostics, challenges currently faced, and the common technologies used.

Please register for a guided virtual tour of Frontage's DMPK facility.

Frontage is a global CRO advancing drug discovery and development with a comprehensive portfolio of genomics services. We deliver accurate and in-depth analyses to move compounds through early discovery and preclinical studies and for translational and clinical programs.

Frontage’s discovery team is comprised of experienced medical chemists, biologists,and DMPK scientists that help Sponsors generate hits and leads. We profile, optimize, and advance the compounds to an IND candidate.